Connect with us
In detail, this new financing was led by Sofinnova Partners and co-managed by Intermediate Capital Group, but the transaction also benefited from the participation of historical...
Johnson & Johnson increased its sales by 1.3% in 2022, up to $95 billion, but reduces profits. Sales in the U.S. rose 2.9% to $12.5 billion...
Doctomatic was created a little over a year ago with the objective of offering a digital platform for the remote management and control of chronic patients....
Aurelian Biotech has patented its new product Biaurelian. The concept of 'biohacking', as explained by Aurelian Biotech, comes from the words 'biology' and 'hacking', and is...
Wivi Vision, which began operating in the Spanish market in December 2019, is undergoing an expansion process throughout the European Union (EU) and is already present...
Galicia complements the European funds received with €4.8 million of its own funds. The value for which these seven pieces of equipment were acquired exceeds €8.2...
With this round, most of the company's capital falls into the hands of the founding team, which controls 70%, while the remaining 30% is distributed among...
Rare diseases are, despite advances, an important area of development for biomedical research, since only 5% of these pathologies have an available treatment. However, current European...
This year, one of the main headaches for managers in the sector will be inflation. GSK and Novartis plan to carry out a double-digit price increase...
AstraZeneca has agreed to acquire CinCor Pharma in a deal that could exceed $1 billion. CinCor Pharma develops treatments for resistant hypertension and chronic kidney disease,...
 |
|
 |  |
 |
|